Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New experiments under Article 51 of the Social Security Financing Act in France

The French Ministry of Solidarity and Health constantly announces the new experiments initiated under Article 51 of the Social Security Financing Act. These experiments are focused on various topics concerning medical technologies and the organization of care. In the period from the end of July to the middle of September, new experiments related to cardiac rehabilitation, digital support for patients with cancer, and personalized perinatal support for women were announced.

Article 51 of the Social Security Financing Act allows for the financing of innovative technologies and organizational schemes in the health sector. In order to receive financing via this framework, the experiments proposed must improve healthcare access, system efficiency, the relevance of prescription, and patient pathway. With this approach, the experimentations can bypass one or more of the 63 regulations of social security financing laws, if it is on the coordination of medical pathway, relevance and quality of health, social or medico-social services, structuration of ambulatory cares and healthcare access.

In the period from the end of July to the middle of September, new experiments under Article 51 of the Social Security Financing Act were announced by the Ministry of Solidarity and Health.

Initiated by stakeholders:

  • READ`HY - Cardiac Rehabilitation Program with remote monitoring and weekly face-to-face evaluation, with total financing of the experiment estimated at €584,877;
  • WALK HOP - Cardiac telerehabilitation for coronary patients stabilized after acute disease and with a low risk of rehabilitation (RARE score ≥2), with total financing of €4,442,227.73;
  • AKO@dom/PICTO - Human and digital support for cancer patients after initiation of drug therapy and/or immunotherapy in the Grand Est region, with total financing of €3,136,136.

Ministerial experiments:

  • RéPAP - personalized perinatal support for women, with total financing of €1,590,553.

The full details in French can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).